{"id": 998035, "name": "Total confirmed bloodstream infections tested for antibiotic susceptibility", "unit": "infections", "createdAt": "2024-11-19T12:34:18.000Z", "updatedAt": "2025-02-12T17:22:41.000Z", "coverage": "", "timespan": "2016-2022", "datasetId": 6807, "columnOrder": 0, "shortName": "total_bcis_with_ast_bloodstream", "catalogPath": "grapher/antibiotics/2024-11-15/testing_coverage/testing_coverage#total_bcis_with_ast_bloodstream", "descriptionShort": "Total bacteriologically confirmed bloodstream infections tested for antibiotic susceptibility.", "type": "int", "dataChecksum": "10428145335925959567", "metadataChecksum": "-2768195121406008143", "datasetName": "Global Antimicrobial Resistance and Use Surveillance System (GLASS) - Testing Coverage", "updatePeriodDays": 365, "datasetVersion": "2024-11-15", "nonRedistributable": false, "display": {"name": "Bloodstream infections", "unit": "infections"}, "schemaVersion": 2, "presentation": {"topicTagsLinks": ["Antibiotics & Antibiotic Resistance"]}, "descriptionKey": ["Acinetobacter spp. infections are tested for their susceptibility to carbapanem antibiotics.", "Salmonella spp. infections are tested for their susceptibility to fluoroquinolone antibiotics.", "Staphylococcus aureus infections are tested for their susceptibility to methicillin antibiotics.", "Escheria coli and Klebsiella pneumoniae infections are tested for their susceptibility to third-generation cephalosporin antibiotics and carbapanem antibiotics.", "Streptococcus pneumoniae infections are tested for their susceptibility to penicillin antibiotics."], "dimensions": {"years": {"values": [{"id": 2016}, {"id": 2017}, {"id": 2018}, {"id": 2019}, {"id": 2020}, {"id": 2021}, {"id": 2022}]}, "entities": {"values": [{"id": 277958, "name": "African Region (WHO)", "code": null}, {"id": 355, "name": "World", "code": "OWID_WRL"}, {"id": 369119, "name": "Eastern Mediterranean (WHO)", "code": null}, {"id": 277955, "name": "European Region (WHO)", "code": null}, {"id": 277957, "name": "Region of the Americas (WHO)", "code": null}, {"id": 277953, "name": "South-East Asia Region (WHO)", "code": null}, {"id": 277952, "name": "Western Pacific Region (WHO)", "code": null}]}}, "origins": [{"id": 2045, "title": "Global Antimicrobial Resistance and Use Surveillance System (GLASS) - Testing Coverage", "description": "GLASS provides a standardized approach to the collection, analysis, interpretation and sharing of data by countries and seeks to actively support capacity building and monitor the status of existing and new national surveillance systems. Furthermore, GLASS promotes a shift from surveillance approaches based solely on laboratory data to a system that includes epidemiological, clinical, and population-level data. GLASS has been conceived to progressively incorporate data from surveillance of AMR in humans, such as monitoring of resistance and the use of antimicrobial medicines, including AMR in the food chain and in the environment.", "producer": "World Health Organization", "citationFull": "Global AMR data - Global Antimicrobial Resistance and Use Surveillance System (GLASS), World Health Organization (2024)", "attributionShort": "WHO", "urlMain": "https://worldhealthorg.shinyapps.io/glass-dashboard/_w_679389fb/#!/amr", "dateAccessed": "2024-11-15", "datePublished": "2024-09-16", "license": {"url": "https://www.who.int/about/policies/terms-of-use", "name": "\u00a9 2024 WHO"}}]}